Molecular Subclasses of Clear Cell Ovarian Carcinoma and Their Impact on Disease Behavior and OutcomesKelly L. Bolton, Elli Papaemmanuil, Denise Chen et al.|Clinical Cancer Research|2022Cited by 103
Validated biomarker assays confirm that <scp>ARID1A</scp> loss is confounded with <scp>MMR</scp> deficiency, <scp> CD8 <sup>+</sup> TIL </scp> infiltration, and provides no independent prognostic value in endometriosis‐associated ovarian carcinomasKarolin Heinze, Yurii B. Shvetsov, Nicola S. Meagher et al.|The Journal of Pathology|2021Cited by 42
Prognostic and Immunological Significance of ARID1A Status in Endometriosis-Associated Ovarian CarcinomaKarolin Heinze, Yurii B. Shvetsov, Tayyebeh M. Nazeran et al.|medRxiv|2021Cited by 4